Business Wire

FPT-CORPORATION

Share
N.R. Narayana Murthy and FPT’s Truong Gia Binh Discuss Vietnam's Future and Foundations of Business Success

In an insightful dialogue themed “Accelerating Values”, Truong Gia Binh, Founder and Chairman of FPT Corporation, engaged with N.R. Narayana Murthy, Founder of Infosys, who shared his visionary outlook on Vietnam's future and the values that drive successful business leadership.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240521592076/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Mr. N.R. Narayana Murthy (L) and Dr. Truong Gia Binh (R) share a conversation regarding “Accelerating Values" (Photo: Business Wire)

The conversation is part of Murthy’s trip to Vietnam. The two leaders addressed a live and webcast audience of over 5,000, including tech leaders, practitioners, and young IT enthusiasts. Both highlighted their shared values and envisioned a future where respect, education, and entrepreneurial spirit accelerate growth and prosperity.

Vietnam's Bright Future

Murthy affirmed Vietnam's recent emergence as a global technology destination, reflecting the country’s commitment and investments. He also spotlighted the courage, hard work, discipline, creativity, and ambition of multiple generations of Vietnamese people. With these qualities, over the next two decades, Vietnam will become a leading developed nation in Asia and one of the fastest-growing globally.

“Vietnam's GDP is already US$4,300 per capita and will continue to grow faster than most economies in the world. I believe Vietnam will achieve prosperity for its people more quickly than many other countries in Asia,” he emphasized.

Respect: The Cornerstone of Success

The Infosys founder underscored the importance of delineating roles in the workplace, highlighting the need for clear boundaries in developing countries to ensure efficient business operations. "Respect from customers translates to profitability and attracts top talent. In my experience, money is not the most important factor — employees seek respect and appreciation for their abilities," he said.

Education and Entrepreneurship

During the conversation, Murthy also discussed the importance of entrepreneurship in driving socio-economic progress, improving lives, and the values needed to build a successful enterprise, from a long-term vision, integrity and humility, to creating favorable conditions for employees and unique values for customers.

He emphasized on the "entrepreneurial spirit", explained that entrepreneurs transform ideas into jobs, and applauded that spirit within FPT, together with the Corporation’s visionary leadership and resilience through the decades. "FPT and Vietnam have no rivals in their courage and aspirations," he affirmed.

Narayana Murthy is widely credited as one of the pioneers of Indian information technology. As India continues to command the world’s leading position in IT, a focus on modern innovations that are central to advancing global technological capabilities, is of critical importance. A 2023 report by Boston Consulting Group and NASSCOM predicts that by 2030, the Software, Automotive, and Semiconductor industries will account for over 60% of India's contributions to global ER&D (Engineering, Research & Development) sourcing. The semiconductor industry plays an especially important role, driven by global efforts to establish India as a hub for semiconductor manufacturing.

Echoing a similar sentiment, FPT Chairman, Truong Gia Binh, asserted that Vietnam’s landscape is now driven by the five areas of Artificial Intelligence, Automotive, Semiconductor, Digital Transformation, and Green Transition. These will continue to play a key role in establishing the nation’s stature in decades to come. Its growing reputation as a technology destination is evident from its thriving digital economy, with FPT as the first Vietnam-headquartered company to enter the Top 50 IT Services Companies in Asia. The Corporation also sets an ambitious target to fully integrate Vietnam into the global semiconductor ecosystem.

“Both Vietnam and India share the common goal of leveraging these sectors to establish ourselves as the key players in the global market. FPT has been doing our part in fueling these movements with our strategic investments, partnerships, development of high-value technology, as well as the emphasis on workforce training and development. We are affirmative that Vietnam can be the answer to these areas, and I am empowered by the continued confidence from an IT visionary like Murthy in FPT’s acceleration together with our country and towards our next billion-dollar milestone,” Binh said.

At the invitation of FPT Corporation, Murthy and his delegation's visit includes a series of activities, such as meeting with Vietnam's Prime Minister Pham Minh Chinh and the country's prominent companies to discuss topics critical to the continued growth of Vietnam’s digital economy, technology advancement across sectors, education, and training, as well as regional stability and development.

About FPT Corporation

FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam. FPT operates in three core sectors: Technology, Telecommunications, and Education. During over three decades of development, FPT has constantly provided practical and effective products to millions of people and tens of thousands of business and non-business organizations worldwide, establishing Vietnam’s position on the global tech map. Keeping up with the latest market trends and emerging technologies, FPT has developed the Made-by-FPT ecosystem of services, products, solutions, and platforms, which enables sustainable growth for organizations and businesses and offers distinctive experiences to customers. In 2023, FPT recorded a total revenue of USD 2.17 billion and 48,000+ employees. For more information, please visit https://fpt.com/en.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240521592076/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release

The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki

Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release

Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release

Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release

SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye